Medline Inc. Deferred Foreign Income Tax Expense (Benefit)
Medline Inc. (MDLN) reported Deferred Foreign Income Tax Expense (Benefit) of -$24.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-25
- Medline Inc. deferred foreign income tax expense (benefit) for fiscal 2025 was -$24.00M.
- Medline Inc. deferred foreign income tax expense (benefit) for fiscal 2024 was -$24.00M.
- Medline Inc. deferred foreign income tax expense (benefit) for fiscal 2023 was -$23.00M.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$24.00M 10-K · filed 2026-02-25 |
| 2024-12-31 | -$24.00M 10-K · filed 2026-02-25 |
| 2023-12-31 | -$23.00M 10-K · filed 2026-02-25 |